Aspen Aerogels (ASPN) Tops Q2 EPS by 15c; Offers FY23 Revenue Guidance
Tweet
Share
E-mailGet Alerts ASPN Hot Sheet
Price: $6.07 --0%
Financial Fact:
Loss on sale and disposal of equipment: 0
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Loss on sale and disposal of equipment: 0
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Aspen Aerogels (NYSE: ASPN) reported Q2 EPS of ($0.22), $0.15 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $48.2 million versus the consensus estimate of $48.81 million.
GUIDANCE:
Aspen Aerogels sees FY2023 revenue of $200-250 million, versus the consensus of $225.7 million.
For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
